Atopic dermatitis: new insight into the etiology, pathogenesis, diagnosis and novel treatment strategies

References

• Kramer ON, Strom MA, Ladizinski B, et al. The history of atopic dermatitis. Clin Dermatol. 2017;35: 344–348.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Oranje A, Deleuran M, et al. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J Eur Acad Dermatol Venereol. 2016;30: 729–747.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70: 338–351.
   PubMed Web of Science ®Google Scholar
• Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112:S128–S139.
   PubMedGoogle Scholar
• Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32: 657–682.
   PubMed Web of Science ®Google Scholar
• Nomura T, Kabashima K. Advances in atopic dermatitis in 2015. J Allergy Clin Immunol. 2016;138: 1548–1555.
   PubMed Web of Science ®Google Scholar
• Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112: S128–S139.
   PubMed Web of Science ®Google Scholar
• Tsakok T, Marrs T, Mohsin M, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol. 2016;137: 1071–1078.
   PubMed Web of Science ®Google Scholar
• Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387: 1109–1122.
   PubMed Web of Science ®Google Scholar
• Thomsen SF, Ulrik CS, Kyvik KO, et al. Importance of genetic factors in the etiology of atopic dermatitis: a twin study. Allergy & Asthma Proc. 2007;28: 535–539.
   PubMed Web of Science ®Google Scholar
• Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38: 441–446.
   PubMed Web of Science ®Google Scholar
• Irvine AD, McLean WHI, Leung DYM. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365: 1315–1327.
   PubMed Web of Science ®Google Scholar
• Douwes J, Pearce N. Asthma and the westernization ‘package’. Int J Epidemiol. 2002;31:1098–1102.
   PubMed Web of Science ®Google Scholar
• Strachan DP. Hay fever, hygiene, and household size. Brit Med J. 1989;299:1259–1260.
   PubMed Web of Science ®Google Scholar
• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–920.
   PubMed Web of Science ®Google Scholar
• von Mutius E. Maternal farm exposure/ingestion of unpasteurized cow's milk and allergic disease. Curr Opin Gastroenterol. 2012;28:570–576.
   PubMed Web of Science ®Google Scholar
• Hong S, Choi WJ, Kwon HJ, et al. Effect of prolonged breast-feeding on risk of atopic dermatitis in early childhood. Allergy Asthma Proc. 2014;35:66–70.
   PubMed Web of Science ®Google Scholar
• Hammer-Helmich L, Linneberg A, Thomsen SF, et al. Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children. Scand J Public Health Suppl. 2014;42:120–127.
   Google Scholar
• Egawa G, Weninger W. Pathogenesis of atopic dermatitis: A short review. Cogent Biol. 2015;1:1–10.
   Web of Science ®Google Scholar
• Proksch E, Fölster-Holst R, Jensen JM. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Sci. 2006;43:159–169.
   PubMed Web of Science ®Google Scholar
• Tamari M, Hirota T. Genome-wide association studies of atopic dermatitis. J Dermatol 2014;41:213–220.
   PubMed Web of Science ®Google Scholar
• Imokawa G. Ceramides as natural moisturizing factors and their efficacy in dry skin. Cosmetic Sci Technol Series. 2002;267–302
   Google Scholar
• Moffatt MF. SPINK5: a gene for atopic dermatitis and asthma. Clin Exp Allergy. 2004;34:325–327.
   PubMed Web of Science ®Google Scholar
• Bieber T. Atopic dermatitis. N Engl J Med 2008;358:1483–1494.
   PubMed Web of Science ®Google Scholar
• Male D, Roitt I. Introduction to the immune system. Immunology. 5th ed. London: Mosby; 1998, 1–12.
   Google Scholar
• Tay SS, Roediger B, Tong PL, et al. The skin-resident immune network. Curr Dermatol Rep. 2013;3:13–22.
   PubMedGoogle Scholar
• Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45:566–574.
   PubMed Web of Science ®Google Scholar
• Grewe M, Bruijnzeel-Koomen CA, Schöpf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998;19:359–361.
   PubMedGoogle Scholar
• Kaesler S, Volz T, Skabytska Y, et al. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4- mediated suppression of IL-10. J Allergy Clin Immunol. 2014;134:92–99.
   PubMed Web of Science ®Google Scholar
• Hamid Q, Naseer T, Minshall EM, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol. 1996;98: 225–231.
   PubMed Web of Science ®Google Scholar
• Takai T, Ikeda S. Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases. Allergol Int. 2011;60:25–35.
   PubMedGoogle Scholar
• Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22:850–859.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42:756–766.
   PubMed Web of Science ®Google Scholar
• Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892–1908.
   PubMed Web of Science ®Google Scholar
• Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118:3–21.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol. 2013;133:1752–1759.
   PubMed Web of Science ®Google Scholar
• Murray AB, Morrison BJ. It is children with atopic dermatitis who develop asthma more frequently if the mother smokes. J Allergy Clin Immunol. 1990;86(5):732–739.
   PubMed Web of Science ®Google Scholar
• Gu H, Chen XS, Chen K, et al. Evaluation of diagnostic criteria for atopic dermatitis: validity of the criteria of Williams et al in a hospital-based setting. Br J Dermatol. 2001;145:428–433.
   PubMed Web of Science ®Google Scholar
• Xu S, Immaneni S, Hazen GB, et al. Cost effectiveness of prophylactic moisturization for atopic dermatitis. JAMA Pediatr. 2017;171: e163909.
   PubMed Web of Science ®Google Scholar
• Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008;122:812–824.
   PubMed Web of Science ®Google Scholar
• Lee JH, Son SW, Cho SH. A comprehensive review of the treatment of atopic eczema. Allergy Asthma Immunol Res. 2016;8:181–190.
   PubMed Web of Science ®Google Scholar
• Gittler JK, Wang JF, Orlow SJ. Bathing and associated treatments in atopic dermatitis. Am J Clin Dermatol. 2017;18: 45–57.
   PubMed Web of Science ®Google Scholar
• Leung DYM, Bieber T. Atopic dermatitis. Lancet. 2003;361:151–160.
   PubMed Web of Science ®Google Scholar
• Wong SM, Ng TG, Baba R. Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J Dermatol. 2013;40:874–880.
   PubMed Web of Science ®Google Scholar
• Mandeau A, Aries MF, Boé JF, et al. Rhealba® oat plantlet extract: evidence of protein-free content and assessment of regulatory activity on immune inflammatory mediators. Planta Med. 2011;77:900–906.
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Frank R, Kroth J, et al. Proactive therapy of atopic eczema–an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7:117–121.
   PubMed Web of Science ®Google Scholar
• Niedner R. Therapy with systemic glucocorticoids. Hautarzt. 2001;52(11):1062–1071.
   PubMed Web of Science ®Google Scholar
• Walsh P, Aeling JL, Huff L, et al. Hypothalamus pituitary- adrenal axis suppression by superpotent topical steroids. J Am Acad Dermatol. 1993;29:501–503.
   PubMed Web of Science ®Google Scholar
• Hajar T, Leshem YA, Hanifin JM, et al. A systematic review of topical corticosteroid withdrawal (“steroid addiction”) in patients with atopic dermatitis and other dermatoses. J Am Acad Dermatol. 2015;72:541–549.
   PubMed Web of Science ®Google Scholar
• Haeck IM, Rouwen TJ, Timmer-de Mik L, et al. Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. J Am Acad Dermatol. 2011;64:275–281.
   PubMed Web of Science ®Google Scholar
• Papier A, Strowd LC. Atopic dermatitis: a review of topical nonsteroid therapy. Drugs Context. 2018;7:212521.
   PubMedGoogle Scholar
• Kyllönen H, Remitz A, Mandelin JM, et al. Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis. Br J Dermatol. 2004;150:1174–1181.
   PubMed Web of Science ®Google Scholar
• Murrell DF, Calvieri S, Ortonne JP, et al. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Br J Dermatol. 2007;157:954–959.
   PubMed Web of Science ®Google Scholar
• Legendre L, Barnetche T, Mazereeuw-Hautier J, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol. 2015;72:992–1002.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Call RS, Forsha DW, et al. Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis. J Am Acad Dermatol. 2017;77:641–649.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Solman L, Williams HC. Magnitude of benefit for topical crisaborole in the treatment of atopic dermatitis in children and adults does not look promising: a critical appraisal. Br J Dermatol. 2018;178:659–662.
   PubMed Web of Science ®Google Scholar
• Peppers J, Paller AS, Maeda-Chubachi T, et al. A phase 2, randomized dose-finding study of tapinar of (GSK2894512 cream) for the treatment of atopic dermatitis. J Am Acad Dermatol. 2019;80:89–98.
   PubMed Web of Science ®Google Scholar
• SP14019-Cyclatop. Pilot study to assess efficacy and safety of 5% topical cyclosporine A in atopic dermatitis. In: 27th Congress of the European Academy of Dermatology and Venereology. 2018, 12–16.
   Google Scholar
• Vakharia PP, Silverberg JI. New therapies for atopic dermatitis: additional treatment classes. J Am Acad Dermatol. 2018;78: S76–S83.
   PubMed Web of Science ®Google Scholar
• Hajar T, Gontijo JRV, Hanifin JM. New and developing therapies for atopic dermatitis. An Bras Dermatol. 2018;93: 104–107.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Papp KA, Poulin Y, et al. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol. 2016;175: 902–911.
   PubMed Web of Science ®Google Scholar
• He H, Guttman-Yassky E. JAK inhibitors for atopic dermatitis: an update. Am J Clin Dermatol. 2019;20: 181–192.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Nemoto O, Igarashi A, et al. Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study. Br J Dermatol. 2018;178: 424–432.
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Silverberg JI, Nemoto O, et al. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. J Am Acad Dermatol. 2019;80: 913–921.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Maari C, Forman S, et al. The oral Janus kinase/spleen tyrosine kinase inhibitorASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomized double-blind placebo-controlled study. Br J Dermatol. 2019;181: 733–742.
   PubMed Web of Science ®Google Scholar
• Patrizi A, Savoia F, Giacomini F, et al. The effect of summer holidays and sun exposure on atopic dermatitis. G Ital Dermatol Venereol. 2009;144: 463–466.
   PubMed Web of Science ®Google Scholar
• Gambichler T, Kreuter A, Tomi NS, et al. Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy. Br J Dermatol 2008;158: 1117–1120.
   PubMed Web of Science ®Google Scholar
• Dotterud LK, Wilsgaard T, Vorland LH, et al. The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls. Int J Circumpolar Health. 2008;67: 254–260.
   PubMed Web of Science ®Google Scholar
• Vähävihu K, Ylianttila L, Salmelin R, et al. Heliotherapy improves vitamin D balance and atopic dermatitis. Br J Dermatol. 2008;158: 1323–1328.
   PubMed Web of Science ®Google Scholar
• Grabbe J, Welker P, Humke S, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol. 1996;107: 419–422.
   PubMed Web of Science ®Google Scholar
• Becker D, Langer E, Seemann M, et al. Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis. PLoS One. 2011;6: e20566.
   PubMed Web of Science ®Google Scholar
• Wollenschläger I, Hermann J, Ockenfels HM. [Targeted UVB-308 nm (NUVB) therapy with excimer laser in the treatment of atopic dermatitis and other inflammatory dermatoses]. Hautarzt. 2009;60: 898–906.
   PubMed Web of Science ®Google Scholar
• Syed S, Weibel L, Kennedy H, et al. A pilot study showing pulsed-dye laser treatment improves localized areas of chronic atopic dermatitis. Clin Exp Dermatol. 2008;33: 243–248.
   PubMed Web of Science ®Google Scholar
• Kawakami T, Kaminishi K, Soma Y, et al. Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis. J Dermatol Sci. 2006;43: 127–134.
   PubMed Web of Science ®Google Scholar
• Malekzad F, Arbabi M, Mohtasham N, et al. Efficacy of oral naltrexone on pruritus in atopic eczema: a double blind, placebo-controlled study. J Eur Acad Dermatol Venereol. 2009;23: 948–950.
   PubMed Web of Science ®Google Scholar
• Ständer S, Böckenholt B, Schürmeyer-Horst F, et al. Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. Acta Derm Venereol. 2009;89: 45–51.
   PubMed Web of Science ®Google Scholar
• Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338: 137–140.
   PubMed Web of Science ®Google Scholar
• Grundmann-Kollmann M, Podda M, Ochsendorf F, et al. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001;137: 870–873.
   PubMed Web of Science ®Google Scholar
• Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375: 2335–2348.
   PubMed Web of Science ®Google Scholar
• Hamilton JD, Suárez-Fariñas M, Dhingra N, et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2014;134(6): 1293–1300.
   PubMed Web of Science ®Google Scholar
• Kim BE, Leung DY, Boguniewicz M, et al. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126: 332–337.
   PubMed Web of Science ®Google Scholar
• Eichenfield L, Flohr C, Simpson E, et al. Lebrikizumab improves patient-reported outcomes (PROs) in a phase 2 study in patients with atopic dermatitis. J Am Acad Dermatol. 2017;76:AB423.
   Google Scholar
• Samrao A, Berry TM, Goreshi R, et al. A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol. 2012;148:890–897.
   PubMed Web of Science ®Google Scholar
• Abrouk M, Farahnik B, Zhu TH, et al. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017;77:177–180.
   PubMed Web of Science ®Google Scholar
• Ruzicka T, Hanifin JM, Furue M, et al. Anti-interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med. 2017;376: 826–835.
   PubMed Web of Science ®Google Scholar
• Holm JG, Agner T, Sand C, et al. Omalizumab for atopic dermatitis: case series and systematic review of the literature. Int J Dermatol. 2016;1:1–9.
   Google Scholar
• Godse K, Mehta A, Patil S, et al. Omalizumab- A Review. Indian J Dermatol. 2015;60: 381–384.
   PubMed Web of Science ®Google Scholar
• Holm JG, Thomsen SF. Omalizumab for atopic dermatitis: evidence for and against its use. In: G Ital Deramtol Venereol. 2019;154:480–487.
   PubMed Web of Science ®Google Scholar
• Simon D, Hösli S, Kostylina G, et al. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008;121:122–128.
   PubMed Web of Science ®Google Scholar
• Wenzel S, Wilbraham D, Fuller R, et al. Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. Lancet. 2007;370:1422–1431.
   PubMed Web of Science ®Google Scholar
• Jacobi A, Antoni C, Manger B, et al. Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol. 2005;52: 522–526.
   PubMed Web of Science ®Google Scholar
• Oldhoff JM, Darsow U, Werfel T, et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy. 2005;60:693–696.
   PubMed Web of Science ®Google Scholar
• Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med. 2014;371:1189–1197.
   PubMed Web of Science ®Google Scholar
• Navarini AA, French LE, Hofbauer GF. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J Allergy Clin Immunol. 2011;128:1128–1130.
   PubMed Web of Science ®Google Scholar
• Gauvreau GM, O’Byrne PM, Boulet LP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014;370:2102–2110.
   PubMed Web of Science ®Google Scholar
• www.clinicaltrials.gov
   Google Scholar
• Akdis CA, Akdis M, Bieber T, et al.; European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118: 152–169.
   PubMed Web of Science ®Google Scholar
• Huang JT, Abrams M, Tlougan B, et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123: e808–e814.
   PubMed Web of Science ®Google Scholar
• Church MK, Maurer M, Simons FE, et al.; Global Allergy and Asthma European Network. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65: 459–466.
   PubMed Web of Science ®Google Scholar
• Glatzer F, Gschwandtner M, Ehling S, et al. Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor. J Allergy Clin Immunol. 2013;132(6): 1358–1367.
   PubMed Web of Science ®Google Scholar
• De Benedetto A, Yoshida T, Fridy S, et al. Histamine and skin barrier: are histamine antagonists useful for the prevention or treatment of atopic dermatitis? J Clin Med. 2015;4(4):741–755.
   PubMed Web of Science ®Google Scholar
• Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database Syst Rev. 2013;4: CD004416.
   Google Scholar
• Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26: 669–675.
   PubMed Web of Science ®Google Scholar
• Darmstadt GL, Saha SK, Ahmed AN, et al. Effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics. 2008;121: 522–529.
   PubMed Web of Science ®Google Scholar
• Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol. 2013;30: 42–50.
   PubMed Web of Science ®Google Scholar
• Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis. 2008;19: 308–315.
   PubMed Web of Science ®Google Scholar
• Evangelista MTP, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double blind, clinical trial. Int J Dermatol. 2014;53: 100–108.
   PubMed Web of Science ®Google Scholar
• Fingleton J, Sheahan D, Corin A, et al. A randomised controlled trial of topical Kanuka honey for the treatment of psoriasis. JRSM Open. 2014;5: 2042533313518913.
   Google Scholar
• Al-Waili NS. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complement Ther Med. 2003;11: 226–234.
   PubMed Web of Science ®Google Scholar
• Koch C, Dölle S, Metzger M, et al. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. Br J Dermatol. 2008;158: 786–792.
   PubMed Web of Science ®Google Scholar
• Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol. 1997;159: 1739–1745.
   PubMed Web of Science ®Google Scholar
• Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014;71: 814–821.
   PubMed Web of Science ®Google Scholar
• Richards HL, Fortune DG, O’Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581–583.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212–216.
   PubMed Web of Science ®Google Scholar
• Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59(1):27–33.
   PubMed Web of Science ®Google Scholar
• Hix E, Gustafson CJ, O’Neill JL, et al. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J. 2013;19(10):20029.
   PubMedGoogle Scholar
• Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol. 2010; 9(4):324–329.
   PubMed Web of Science ®Google Scholar
• Furue M, Onozuka D, Takeuchi S, et al. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015; 172(1):272–275.
   PubMed Web of Science ®Google Scholar
• Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010;894258.
   PubMedGoogle Scholar
• Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol. 2011;28(3):242–244.
   PubMed Web of Science ®Google Scholar
• Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol. 2001;117(4):852–857.
   PubMed Web of Science ®Google Scholar
• Serup J, Lindblad AK, Maroti M, et al. To follow or not to follow dermatological treatment. Acta Derm Venereol. 2006;86(3):193–197.
   PubMed Web of Science ®Google Scholar
• Ulff E, Maroti M, Kettis-Lindblad Å, et al. Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites. Br J Dermatol. 2007;156(5):974–978.
   PubMed Web of Science ®Google Scholar
• Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011; 165(4):808–814.
   PubMed Web of Science ®Google Scholar
• Hon K-LE, Kam W-YC, Leung T-F, et al. Steroid fears in children with eczema. Acta Paediatr. 2006; 95(11):1451–1455.
   PubMed Web of Science ®Google Scholar
• El Hachem M, Gesualdo F, Ricci G, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017; 43(1):22.
   PubMedGoogle Scholar
• Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–936.
   PubMed Web of Science ®Google Scholar
• Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015; 27(5):499–506.
   PubMed Web of Science ®Google Scholar
• Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 2013;1830(6):3670–3695.
   PubMed Web of Science ®Google Scholar
• Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: concept of ayurveda. Pharmacog Rev. 2014;8(16):73–80.
   PubMedGoogle Scholar
• Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L, Schwaiger S, Heiss EH, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582–1614.
   PubMed Web of Science ®Google Scholar
• Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11(3):191–200.
   PubMed Web of Science ®Google Scholar
• Saha S, Sadhukhan P, Mahalanobish S, Dutta S, Sil PC. Ameliorative role of genistein against age dependent chronic arsenic toxicity in murine brains via the regulation of oxidative stress and inflammatory signaling cascades. J Nutritional Biochem. 2018;55:26–40.
   PubMed Web of Science ®Google Scholar
• Huffman MA. Self-medicative behavior in the African great apes: An evolutionary perspective into the origins of human traditional medicine. Bioscience. 2001;51(8):651–661.2.0.CO;2]
   Web of Science ®Google Scholar
• Ghazanfar SA. Handbook of Arabian medicinal plants. Boca Raton, FL: CRC Press; 1994.
   Google Scholar
• Kapoor LD. CRC handbook of Ayurvedic medicinal plants. Boca Raton, FL: CRC Press; 1990.
   Google Scholar
• Xu Y. Dermatology in Traditional Chinese Medicine. St. Albans, UK: Donica Publishing Ltd.; 2004
   Google Scholar
• Wollenberg A, Reitamo S, Atzori F, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy Eur J Allergy Clin Immunol. 2008;63:742–750.
   Google Scholar
• Leung DYM. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000;105:860–876.
   PubMed Web of Science ®Google Scholar
• Bae MJ, Lim S, Lee DS, et al. Water soluble extracts from Actinidia arguta, PG102, attenuates house dust mite-induced murine atopic dermatitis by inhibiting the mTOR pathway with Treg generation. J Ethnopharmacol. 2016;193:96–106.
   PubMed Web of Science ®Google Scholar
• Choi Y, Choi JK, Jang YH, et al. Antiinflammatory effect of Amomum xanthioides in a mouse atopic dermatitis model. Mol Med Rep. 2017;16:8964–8972.
   PubMed Web of Science ®Google Scholar
• Ku JM, Hong SH, Kim HI, et al. Effects of Angelicae dahuricae Radix on 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice model. BMC Complement Altern Med. 2017;17:1–8.
   PubMed Web of Science ®Google Scholar
• Han HM, Kim SJ, Kim JS, et al. Ameliorative effects of Artemisia argyi Folium extract on 2, 4dinitrochlorobenzeneinduced atopic dermatitislike lesions in BALB/c mice. Mol Med Rep. 2016;14:3206–3214.
   PubMed Web of Science ®Google Scholar
• Yun C, Jung Y, Chun W, et al. Anti-inflammatory effects of Artemisia leaf extract in mice with contact dermatitis in vitro and in vivo. Mediat Inflamma. 2016;2016:8027537.
   PubMed Web of Science ®Google Scholar
• Ryu KJ, Yoou MS, Seo Y, et al. Therapeutic effects of Artemisia scoparia Waldst. et Kitaib in a murine model of atopic dermatitis. Clin Exp Dermatol. 2018;43:798–805.
   PubMed Web of Science ®Google Scholar
• Qi XF, Kim DH, Yoon YS, et al. Effects of Bambusae caulis in Liquamen on the development of atopic dermatitis-like skin lesions in hairless mice. J Ethnopharmacol. 2009; 123: 195–200.
   PubMed Web of Science ®Google Scholar
• Kim EC, Lee HS, Kim SK, et al. The bark of Betula platyphylla var. japonica inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. J Ethnopharmacol. 2008;116:270–278.
   PubMed Web of Science ®Google Scholar
• Lee JK, Ha H, Lee HY, et al. Inhibitory effects of heartwood extracts of Broussonetia kazinoki sieb on the development of atopic dermatitis in NC/Nga mice. Biosci Biotechnol Biochem. 2010;74:1802–1806.
   PubMed Web of Science ®Google Scholar
• Um YL, Jo YW. Inhibitory effects of calophyllum inophyllum extract on atopic dermatitis induced by DNCB in mouse. Am J Phytomed Clin Thera. 2016;4:165–173.
   Google Scholar
• Hong SH, Ku JM, Kim HI, et al. Oral administration of Cervus nippon mantchuricus extract suppresses 2, 4-dinitrochlorobenzene-induced atopic dermatitis in BALB/c mice and inflammatory effects in mast cells. Int J Mol Med. 2018;42:2961–2971.
   PubMed Web of Science ®Google Scholar
• Sung YY, Yoon T, Jang JY, et al. Inhibitory effects of Cinnamomum cassia extract on atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice. J Ethnopharmacol. 2011;133:621–628.
   PubMed Web of Science ®Google Scholar
• Wu G, Li L, Sung GH, et al. Inhibition of 2, 4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice. J Ethnopharmacol. 2011;134:504–509.
   PubMed Web of Science ®Google Scholar
• Choi YY, Kim MH, Lee H, et al. Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice. Biomed Pharmacother. 2017;90:321–327.
   PubMed Web of Science ®Google Scholar
• Yang B, Lyu JH, Kim S, et al. Dictamnus dasycarpus Turcz., root bark alleviates oxazolone-induced atopy-like dermatitis in mice. Pharmacog Mag. 2019;15:219–255.
   Web of Science ®Google Scholar
• Sung YY, Yoon T, Jang S, et al. Forsythia suspensa suppresses house dust mite extract-induced atopic dermatitis in NC/Nga mice. PLoS One. 2016;11:e0167687.
   PubMed Web of Science ®Google Scholar
• Debnath T, Lee YM, Lim JH, et al. Anti-allergic and anti-atopic dermatitis effects of Gardenia Fructus extract. Food Agr Immunol. 2018;29:665–674.
   Web of Science ®Google Scholar
• Kim T, Park K, Jung HS, et al. Evaluation of anti‐atopic dermatitis activity of Hypsizigus marmoreus extract. Phytother Res. 2014;28:1539–1546.
   PubMed Web of Science ®Google Scholar
• Lim HS, Ha H, Lee H, et al. Morus alba L. suppresses the development of atopic dermatitis induced by the house dust mite in NC/Nga mice. BMC Complement Altern Med. 2014;14:1–8.
   PubMed Web of Science ®Google Scholar
• Lee JH, Cho SH. Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: an atopic dermatitis model. J Ethnopharmacol. 2011;133:810–817.
   PubMed Web of Science ®Google Scholar
• Heo JC, Nam DY, Seo MS, et al. Alleviation of atopic dermatitis-related symptoms by Perilla frutescens Britton. Int J Mol Med. 2011;28:733–737.
   PubMed Web of Science ®Google Scholar
• Kim MS, Hur YG, Kim WG, et al. Inhibitory effect of Platycodon grandiflorum on TH1 and TH2 immune responses in a murine model of 2, 4-dinitrofluorobenzene–induced atopic dermatitis–like skin lesions. Ann Allergy Asthma Immunol. 2011;106:54–61.
   PubMed Web of Science ®Google Scholar
• Choi YY, Kim MH, Ahn KS, et al. Immunomodulatory effects of Pseudostellaria heterophylla (Miquel) Pax on regulation of Th1/Th2 levels in mice with atopic dermatitis. Mol Med Rep. 2017;15:649–656.
   PubMed Web of Science ®Google Scholar
• Cho K, Parveen A, Kang MC, et al. Pyrus ussuriensis Maxim. leaves extract ameliorates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. Phytomed. 2018;48:76–83.
   PubMed Web of Science ®Google Scholar
• Jin JH, Ngoc TM, Bae K, et al. Inhibition of experimental atopic dermatitis by rhubarb (rhizomes of Rheum tanguticum) and 5‐lipoxygenase inhibition of its major constituent, emodin. Phytother Res. 2011;25:755–759.
   PubMed Web of Science ®Google Scholar
• Lim HS, Ha H, Lee MY, et al. Saussurea lappa alleviates inflammatory chemokine production in HaCaT cells and house dust mite-induced atopic-like dermatitis in Nc/Nga mice. Food Chem Toxicol. 2014;63:212–220.
   PubMed Web of Science ®Google Scholar
• Kang TH, Shin HM. Inhibitory effects of Schizandra chinensis extract on atopic dermatitis in NC/Nga mice. Immunopharmacol Immunotoxicol. 2012;34;292–298.
   PubMed Web of Science ®Google Scholar
• Kim J, Seok Lee I, Park S, et al. Effects of Scutellariae radix and Aloe vera gel extracts on immunoglobulin E and cytokine levels in atopic dermatitis NC/Nga mice. J Ethnopharmacol 2010;132:529–532.
   PubMed Web of Science ®Google Scholar
• Kang SY, Jung HW, Nam JH, et al. Effects of the fruit extract of Tribulus terrestris on skin inflammation in mice with oxazolone-induced atopic dermatitis through regulation of calcium channels, Orai-1 and TRPV3, and mast cell activation. Evid Complement Alternat Med. 2017;2017:8312946.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim JR, Kang H, et al. 7, 8, 4′-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PLoS One. 2014;9:e104938.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee YS, Lee EJ, et al. Capsiate inhibits DNFB-induced atopic dermatitis in NC/Nga mice through mast cell and CD4+ T-cell inactivation. J Investig Dermatol. 2015;135:1977–1985.
   PubMed Web of Science ®Google Scholar
• Ha H, Lee H, Seo CS, et al. Artemisia capillaris inhibits atopic dermatitis-like skin lesions in Dermatophagoides farinae-sensitized Nc/Nga mice, BMC Complement Altern Med. 2014; 14: 100.
   PubMed Web of Science ®Google Scholar
• Han NR, Moon PD, Kim HM, et al. Cordycepin ameliorates skin inflammation in a DNFB-challenged murine model of atopic dermatitis. Immunopharmacol Immunotoxicol. 2018;40:401–407.
   PubMed Web of Science ®Google Scholar
• Sung YY, Kim HK. Crocin ameliorates atopic dermatitis symptoms by down regulation of Th2 response via blocking of NF-kappaB/STAT6 signaling pathways in mice. Nutrients. 2018; 10: 1625.
   PubMed Web of Science ®Google Scholar
• Lee S, Park NJ, Bong SK, et al. Ameliorative effects of Juniperus rigida fruit on oxazolone-and 2, 4-dinitrochlorobenzene-induced atopic dermatitis in mice. J Ethnopharmacol. 2018;214:160–167.
   PubMed Web of Science ®Google Scholar
• Jung AR, Ahn SH, Park IS, et al. Douchi (fermented Glycine max Merr.) alleviates atopic dermatitis-like skin lesions in NC/Nga mice by regulation of PKC and IL-4. BMC Complement Altern Med. 2016;16:1–4.
   PubMed Web of Science ®Google Scholar
• Lee J, Choi YY, Kim MH, et al. Topical application of Angelica sinensis improves pruritus and skin inflammation in mice with atopic dermatitis-like symptoms. J Med Food 2016;19:98–105.
   PubMed Web of Science ®Google Scholar
• Bae MJ, See HJ, Choi G, et al. Regulatory T cell induced by Poria cocos bark exert therapeutic effects in murine models of atopic dermatitis and food allergy. Mediators Inflamm. 2016;2016:3472608.
   PubMed Web of Science ®Google Scholar
• Tsang MS, Jiao D, Chan BC, et al. Anti-inflammatory activities of pentaherbs formula, berberine, gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation. Molecules. 2016; 21: 519.
   PubMed Web of Science ®Google Scholar
• Sung YY, Lee AY, Kim HK. The Gardenia jasminoides extract and its constituent, geniposide, elicit anti-allergic effects on atopic dermatitis by inhibiting histamine in vitro and in vivo. J Ethnopharmacol. 2014;156:33–40.
   PubMed Web of Science ®Google Scholar
• Choi JH, Jin SW, Park BH, et al. Cultivated ginseng inhibits 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice and TNF-α/IFN-γ-induced TARC activation in HaCaT cells. Food Chem Toxicol. 2013;56:195–203.
   PubMed Web of Science ®Google Scholar
• Park JH, Ahn EK, Ko HJ, et al. Korean red ginseng water extract alleviates atopic dermatitis-like inflammatory responses by negative regulation of mitogen-activated protein kinase signaling pathway in vivo. Biomed Pharmacother. 2019;117:109066.
   PubMed Web of Science ®Google Scholar
• Lee BH, Kim HK, Jang M, et al. Effects of gintonin-enriched fraction in an atopic dermatitis animal model: involvement of autotaxin regulation. Biol Pharm Bull. 2017;40:1063–1070.
   PubMed Web of Science ®Google Scholar
• Han NR, Park JY, Jang JB, et al. A natural dye, Niram improves atopic dermatitis through down-regulation of TSLP. Environ Toxicol Pharmacol. 2014;38:982–990.
   PubMed Web of Science ®Google Scholar
• Sur B, Lee B, Yoon YS, et al. Extract of polygala tenuifolia alleviates stress-exacerbated atopy-like skin dermatitis through the modulation of protein Kinase A and p38 mitogen-activated protein Kinase signaling pathway. Int J Mol Sci. 2017;18:190.
   Web of Science ®Google Scholar
• Park G, Kim HG, Lim S, et al. Coriander alleviates 2, 4-dinitrochlorobenzene-induced contact dermatitis-like skin lesions in mice. J Med Food. 2014; 17: 862–868.
   PubMed Web of Science ®Google Scholar
• Cha HY, Ahn SH, Cheon JH, et al. Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC/Nga mice under high-fat diet conditions. Evid Complement Alternat Med. 2016;2016:1739760.
   PubMed Web of Science ®Google Scholar
• Choi YY, Kim MH, Lee JY, et al. Topical application of Kochia scoparia inhibits the development of contact dermatitis in mice. J Ethnopharmacol. 2014;154:380–385.
   PubMed Web of Science ®Google Scholar
• Kim TH, Kim GD, Ahn HJ, et al. The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice. Life Sci. 2013;93:516–524.
   PubMed Web of Science ®Google Scholar
• Sung YY, Kim DS, Yang WK, et al. Inhibitory effects of Drynaria fortunei extract on house dust mite antigen-induced atopic dermatitis in NC/Nga mice. J Ethnopharmacol. 2012;144:94–100.
   PubMed Web of Science ®Google Scholar
• Choi SE, Park KH, Jeong MS, et al. Effect of Alnus japonica extract on a model of atopic dermatitis in NC/Nga mice. J Ethnopharmacol. 2011;136:406–413.
   PubMed Web of Science ®Google Scholar
• Lin L, Zhou Y, Li H, et al. Polysaccharide extracted from Chinese white wax scale ameliorates 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like symptoms in BALB/c mice. Saudi Pharm J. 2017;25:625–632.
   PubMed Web of Science ®Google Scholar
• Wu CT, Huang KS, Yang CH, et al. Inhibitory effects of cultured Dendrobium tosaense on atopic dermatitis murine model. Int J Pharm. 2014;463:193–200.
   PubMedGoogle Scholar
• Sozmen SC, Karaman M, Micili SC, et al. Resveratrol ameliorates 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium. Peer J. 2016;4:e1889.
   PubMed Web of Science ®Google Scholar
• Lee H, Ha H, Lee JK, et al. The leaves of Broussonetia kazinoki siebold inhibit atopic dermatitis-like response on mite allergen-treated Nc/Nga mice. Biomol Ther. 2014;22:438–444.
   PubMed Web of Science ®Google Scholar
• Yang IJ, Lee DU, Shin HM. Inhibitory effect of valencene on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Evid Complement Alternat Med. 2016;2016:9370893.
   PubMed Web of Science ®Google Scholar
• Yang JH, Yoo JM, Cho WK, et al. Ethanol extract of sanguisorbae radix inhibits mast cell degranulation and suppresses 2, 4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions. Mediators Inflamm. 2016;2016:2947390.
   PubMed Web of Science ®Google Scholar
• Amagai Y, Katsuta C, Nomura Y, et al. Amelioration of atopic‐like skin conditions in NC/Tnd mice by topical application with distilled Alpinia intermedia Gagnep extracts. J Dermatol. 2017;44:1238–1247.
   PubMed Web of Science ®Google Scholar
• Akhtar N, Verma A, Pathak K. Exploring preclinical and clinical effectiveness of nanoformulations in the treatment of atopic dermatitis: Safety aspects and patent reviews. Bull Fac Pharm Cairo Univ. 2017;55:1 21.
   Google Scholar
• Vavrova K. Emerging small-molecule compounds for treatment of atopic dermatitis: a review. Expert Opin Ther Pat. 2016;26:21–34.
   PubMed Web of Science ®Google Scholar